These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8944418)

  • 1. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
    Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
    Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
    Abrahamsson T; Nerme V; Strömqvist M; Akerblom B; Legnehed A; Pettersson K; Westin Eriksson A
    Thromb Haemost; 1996 Jan; 75(1):118-26. PubMed ID: 8713790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide attenuates thrombolysis in batroxobin-induced lung vasculature fibrin deposition but not in ferrous chloride-induced carotid artery thrombus in rats: role of endogenous PAI-1.
    Wang YX; Dong N; Wu C; Martin-McNulty B; Fitch RM; da Cunha V; Vicelette J; Tran K; Vergona R; Sullivan ME; Morser J; Wu Q
    Thromb Res; 2003; 111(6):381-7. PubMed ID: 14698657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic influence on secondary generalized fibrinolysis].
    Markwardt F; Drawert J; Perlewitz J
    Acta Biol Med Ger; 1979; 38(8):1201-9. PubMed ID: 532498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
    Li N; He S; Blombäck M; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):407-13. PubMed ID: 17138937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis.
    He S; Blombäck M; Bark N; Johnsson H; Wallén NH
    Thromb Haemost; 2010 May; 103(5):1076-84. PubMed ID: 20216982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
    Urano T; Ihara H; Takada Y; Fujie M; Takada A
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
    He S; Johnsson H; Zabczyk M; Hultenby K; Cao H; Blombäck M
    Br J Haematol; 2013 Mar; 160(6):806-16. PubMed ID: 23360261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M; Gustafsson D; Deinum J
    Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of argatroban on staphylokinase induced thrombolysis of platelet rich thrombi in rat mesenteric venules in vivo.
    Kawano M; Watanabe S; Sasaki Y; Giddings JC; Yamamoto J
    Thromb Res; 1997 Apr; 86(2):115-26. PubMed ID: 9175233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1984; 30(2):95-100. PubMed ID: 6540008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin.
    Moroz LA; Gilmore NJ
    Blood; 1975 Oct; 46(4):543-53. PubMed ID: 126094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.